XIST, LINC00173, FBN1, COL1A1, COL5A1, and BGN were identified as key molecules in the network, which have potential diagnostic value and may be therapeutic targets for ARVC. The gene discussed is XIST; the disease is arrhythmogenic right ventricular cardiomyopathy.